mitomycin has been researched along with Cancer of Esophagus in 85 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This prospective study aimed to evaluate the feasibility and safety of locoregional mitomycin C (MMC) injection to treat refractory esophageal strictures after endoscopic submucosal dissection (ESD) for superficial esophageal carcinoma." | 9.16 | Locoregional mitomycin C injection for esophageal stricture after endoscopic submucosal dissection. ( Arakawa, T; Fujiwara, Y; Machida, H; Minamino, H; Okazaki, H; Sugimori, S; Tanigawa, T; Tominaga, K; Watanabe, K; Watanabe, T; Yamagami, H, 2012) |
| "Based on the observation of topoisomerase-1, upregulation by mitomycin C (MMC), and the phase I antitumor activity of sequential MMC/irinotecan in esophageal cancer, we conducted a phase II evaluation of two schedules of this combination in previously untreated stage III/IV esophageal/gastroesophageal junction adenocarcinomas." | 9.14 | Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma. ( Abbas, A; Bekaii-Saab, T; Burak, W; Lustberg, MB; Lustberg, ME; McCracken-Bussa, B; Otterson, G; Villalona-Calero, MA; Young, D, 2010) |
| "All patients who underwent balloon dilation followed by topical Mitomycin C application for recurrent benign esophageal strictures were included." | 8.93 | Topical Mitomycin C application in the treatment of refractory benign esophageal strictures in adults and comprehensive literature review. ( Bartel, MJ; Clayton, D; Jeffers, K; Raimondo, M; Seeger, K; Wallace, MB; Woodward, TA, 2016) |
| "To assess the role of mitomycin C (MMC) in the management of pharyngoesophageal stricture after total laryngopharyngectomy and free flap reconstruction." | 7.72 | Mitomycin C for the treatment of pharyngoesophageal stricture after total laryngopharyngectomy and microvascular free tissue reconstruction. ( Annino, DJ; Goguen, LA, 2003) |
| "We reviewed our results with chemotherapy for adenocarcinoma of the esophagus or gastroesophageal junction tumors in patients treated with 5-fluorouracil, Adriamycin, and mitomycin C (FAM) regimen as developed by MacDonald and colleagues for adenocarcinoma of the stomach." | 7.69 | 5-Fluorouracil, adriamycin, and mitomycin C in adenocarcinoma of the esophagus or gastroesophageal junction tumors. ( Allred, C; Khansur, T; Tavassoli, M, 1994) |
| "We have evaluated the effect of 5-fluorouracil 600 mg/m2, doxorubicin ('Adriamycin') 40 mg/m2, and Mitomycin-C 4 mg/m2 (FAM) in two groups of patients with adenocarcinoma of the oesophagus, as either a preoperative or primary treatment." | 7.68 | A phase II study of 5-fluorouracil, adriamycin and mitomycin-C in adenocarcinoma of the oesophagus. ( Allen, SM; Cullen, MH; Matthews, HR; Steel, A; Walker, SJ, 1991) |
| "Etoposide is a topoisomerase II inhibitor with evidence for phase-specific and schedule-dependent activity." | 6.68 | A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract. ( Boardman, P; Braybrooke, JP; Ganesan, TS; Harris, AL; O'Byrne, KJ; Propper, DJ; Salisbury, AJ; Saunders, MP; Talbot, DC; Taylor, M, 1997) |
| "Mitomycin C (10 mg/m2) was administered as a bolus injection on day 2." | 5.28 | Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. ( Coia, LR; Engstrom, PF; Hanks, GE; Paul, AR; Stafford, PM, 1991) |
| "This prospective study aimed to evaluate the feasibility and safety of locoregional mitomycin C (MMC) injection to treat refractory esophageal strictures after endoscopic submucosal dissection (ESD) for superficial esophageal carcinoma." | 5.16 | Locoregional mitomycin C injection for esophageal stricture after endoscopic submucosal dissection. ( Arakawa, T; Fujiwara, Y; Machida, H; Minamino, H; Okazaki, H; Sugimori, S; Tanigawa, T; Tominaga, K; Watanabe, K; Watanabe, T; Yamagami, H, 2012) |
| "Based on the observation of topoisomerase-1, upregulation by mitomycin C (MMC), and the phase I antitumor activity of sequential MMC/irinotecan in esophageal cancer, we conducted a phase II evaluation of two schedules of this combination in previously untreated stage III/IV esophageal/gastroesophageal junction adenocarcinomas." | 5.14 | Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma. ( Abbas, A; Bekaii-Saab, T; Burak, W; Lustberg, MB; Lustberg, ME; McCracken-Bussa, B; Otterson, G; Villalona-Calero, MA; Young, D, 2010) |
| "All patients who underwent balloon dilation followed by topical Mitomycin C application for recurrent benign esophageal strictures were included." | 4.93 | Topical Mitomycin C application in the treatment of refractory benign esophageal strictures in adults and comprehensive literature review. ( Bartel, MJ; Clayton, D; Jeffers, K; Raimondo, M; Seeger, K; Wallace, MB; Woodward, TA, 2016) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "To assess the role of mitomycin C (MMC) in the management of pharyngoesophageal stricture after total laryngopharyngectomy and free flap reconstruction." | 3.72 | Mitomycin C for the treatment of pharyngoesophageal stricture after total laryngopharyngectomy and microvascular free tissue reconstruction. ( Annino, DJ; Goguen, LA, 2003) |
| "The multidrug resistance gene product P-glycoprotein (P-GP) was assessed immunohistochemically (by antibody JSB-1) in biopsy specimens from 27 oesophageal squamous carcinomas and 10 adenocarcinomas before treatment with mitomycin, ifosfamide and cisplatin (MIC)." | 3.69 | Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer. ( Darnton, SJ; Ferry, DR; Jenner, K; Matthews, HR; Steyn, RS, 1995) |
| "We reviewed our results with chemotherapy for adenocarcinoma of the esophagus or gastroesophageal junction tumors in patients treated with 5-fluorouracil, Adriamycin, and mitomycin C (FAM) regimen as developed by MacDonald and colleagues for adenocarcinoma of the stomach." | 3.69 | 5-Fluorouracil, adriamycin, and mitomycin C in adenocarcinoma of the esophagus or gastroesophageal junction tumors. ( Allred, C; Khansur, T; Tavassoli, M, 1994) |
| "Of 13 patients with adenocarcinoma treated with 5-fluorouracil, adriamycin, and mitomycin (FAM), nine showed minor histological changes compared with 14 control cases." | 3.68 | Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy. ( Allen, SM; Darnton, SJ; Edwards, CW; Matthews, HR, 1993) |
| "Ten resected oesophageal adenocarcinomas treated with preoperative chemotherapy--mitomycin-C, ifosfamide, and cisplatin (MIC)--were examined by transmission electron microscopy and their appearance compared with that of 13 concurrent untreated resected oesophageal adenocarcinomas." | 3.68 | Effects of chemotherapy on ultrastructure of oesophageal adenocarcinoma. ( Antonakopoulos, GN; Darnton, SJ; Matthews, HR; Newman, J, 1992) |
| "A 63-year-old male had undergone combination chemotherapy including adriamycin, cisplatin, mitomycin C, 5-fluorouracil and vindesine for six months for double cancer of esophagus and stomach." | 3.68 | [Chemotherapy-associated hemolytic uremic syndrome--a case report]. ( Kanamaru, R; Kikuchi, H, 1992) |
| "We have evaluated the effect of 5-fluorouracil 600 mg/m2, doxorubicin ('Adriamycin') 40 mg/m2, and Mitomycin-C 4 mg/m2 (FAM) in two groups of patients with adenocarcinoma of the oesophagus, as either a preoperative or primary treatment." | 3.68 | A phase II study of 5-fluorouracil, adriamycin and mitomycin-C in adenocarcinoma of the oesophagus. ( Allen, SM; Cullen, MH; Matthews, HR; Steel, A; Walker, SJ, 1991) |
| "Patients with local/regional oesophageal cancer with adequate functional status should not be excluded from potentially curative treatment based on age alone." | 2.73 | Combined modality chemoradiation in elderly oesophageal cancer patients. ( Anderson, SE; Bains, M; Hummer, A; Ilson, DH; Kelsen, D; Minsky, BD, 2007) |
| "Grade 3/4 neutropenia was observed in 21 % of patients and grade 3/4 febrile neutropenia was seen in only one patient." | 2.73 | Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma. ( Ahn, JS; Ahn, MJ; Hwang, IG; Im, YH; Kang, WK; Lee, SC; Lim, HY; Park, BB; Park, K, 2008) |
| "Between 1994 and 1997, 22 patients with dysphagia from advanced incurable esophageal cancer were enrolled in a phase I/II prospective study to assess the palliative benefit and toxicity of a short course of radiotherapy with chemotherapy." | 2.69 | A prospective trial of short-course radiotherapy plus chemotherapy for palliation of dysphagia from advanced esophageal cancer. ( Hayter, CR; Huff-Winters, C; Paszat, L; Schulze, K; Shelley, WE; Youssef, YM, 2000) |
| "Etoposide is a topoisomerase II inhibitor with evidence for phase-specific and schedule-dependent activity." | 2.68 | A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract. ( Boardman, P; Braybrooke, JP; Ganesan, TS; Harris, AL; O'Byrne, KJ; Propper, DJ; Salisbury, AJ; Saunders, MP; Talbot, DC; Taylor, M, 1997) |
| "Neo-adjuvant therapy with MIC in squamous carcinoma of the oesophagus has shown encouraging early results, with acceptable toxicity." | 2.67 | A phase II study of mitomycin, ifosfamide and cisplatin in operable and inoperable squamous cell carcinoma of the oesophagus. ( Allen, SM; Cullen, MH; Darnton, SJ; Duffy, JP; Matthews, HR; Walker, SJ, 1994) |
| "Esophageal cancer is supposed to be more sensitive to chemotherapy compared to other gastrointestinal cancers." | 2.42 | [Chemotherapy for esophageal cancer]. ( Nabeya, Y; Ochiai, T, 2003) |
| "Treatment options for oesophageal cancer have changed considerably over the last decades with the introduction of multimodal treatment concepts dominating the progress in the field." | 1.38 | Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre. ( Belka, C; Hölzel, D; Schmidt, M; Wolf, MC; Zehentmayr, F, 2012) |
| "298 patients with inoperable cancer of the esophagus were identified (16." | 1.36 | Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer. ( Belka, C; Ganswindt, U; Haimerl, W; Hölzel, D; Niyazi, M; Schmidt, M; Wolf, M; Zehentmayr, F, 2010) |
| " 60Co gamma-irradiation or 6MVX-ray with conventional fraction were used for radiotherapy with a total volume dosage of 55-70 Gy." | 1.34 | [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus]. ( Han, JQ; Li, XQ; Liang, RX; Liu, Q; Qu, FS; Sun, YH; Yan, TX, 2007) |
| "In patients with pancreatic cancer, the overall response rate was 42% with a median survival of 8 months." | 1.31 | Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers - a new active regimen. ( Gallagher, CJ; Shamash, J; Slater, S; Slevin, ML; Wilson, P, 2002) |
| " Thirty-one patients with superficial oesophageal or gastric cardiac carcinomas, who refused or were unsuitable for surgery, received endoscopic Nd:YAG laser therapy combined with local injection of chemotherapeutic drugs 5-fluorouracil and mitomycin." | 1.31 | Endoscopic Nd:YAG laser therapy combined with local chemotherapy of superficial carcinomas of the oesophagus and gastric cardia. ( Huang, T; Jia, J; Wang, Y; Zhou, C, 2001) |
| "Acute toxicity was well tolerated and dysphagia was improved in 35 patients (65%), with 28 (52%) eating a normal diet by week 12." | 1.30 | Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus. ( Dische, S; Foy, CJ; Hoskin, PJ; Powell, ME; Saunders, MI, 1997) |
| "Seven oesophageal squamous carcinomas, treated with pre-operative chemotherapy (mitomycin-C, ifosfamide and cisplatin-MIC), with a course finishing 21 days prior to resection, were examined by electronmicroscopy." | 1.29 | Effects of chemotherapy on ultrastructure of oesophageal squamous cell carcinoma. ( Antonakopoulos, GN; Darnton, SJ; Duffy, JP; Matthews, HR; Newman, J, 1994) |
| " SOD-POE did not influence the antitumor effects of ADR and MMC either in vitro or in vivo, but prevented the toxic death of BALB/c, nu/nu male mice caused by overdoses of ADR or MMC." | 1.28 | Polyoxyethylene-modified superoxide dismutase reduces side effects of adriamycin and mitomycin C. ( Akiyama, S; Dohmitsu, K; Ito, K; Kataoka, M; Kawasaki, S; Kondoh, K; Kurokawa, T; Sugiyama, S; Watanabe, T; Yamauchi, M, 1992) |
| "Mitomycin C (10 mg/m2) was administered as a bolus injection on day 2." | 1.28 | Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. ( Coia, LR; Engstrom, PF; Hanks, GE; Paul, AR; Stafford, PM, 1991) |
| "There are few reports about the methods, amounts, and kinds of dosage about intermittent intra-arterial chemotherapy of liver metastases from primal pathological type's squamous cell carcinoma." | 1.28 | [Study of intermittent intra-arterial infusion chemotherapy in liver metastases from squamous cell carcinoma]. ( Aoki, T; Kasuya, K; Kimura, K; Koyanagi, Y; Ozawa, T; Sato, S; Tsuchida, A; Yasuda, D; Yoshimatsu, A, 1991) |
| "Of 25 patients with squamous cell carcinoma, 13 underwent esophagectomy." | 1.28 | Cisplatin, 5-fluorouracil, mitomycin C, and concurrent radiation therapy with and without esophogectomy for esophageal carcinoma. ( Daniel, TM; Hahn, SS; Harkins, BJ; Stewart, FM, 1989) |
| "The PR cases were 4 of stomach cancer and 2 of lung cancer, the former being all undifferentiated adenocarcinoma." | 1.27 | [Phase II study of KW 2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with various cancers]. ( Harashima, S; Kanko, T; Nakao, I; Nishi, I; Ohashi, Y; Saito, T; Yokoyama, T, 1984) |
| "Of 55 patients with esophageal squamous cell carcinoma, 30 with localized disease were treated with a combined modality for curative intent." | 1.27 | Combined modality therapy for esophageal squamous cell carcinoma. ( Asfaw, I; Franklin, R; Hoschner, J; Loh, J; Miller, P; Rosenberg, J; Steiger, Z; Vaishampayan, G, 1983) |
| "Twenty-one consecutive patients with squamous cell carcinoma of the esophagus (EC) were referred, with advanced Stage III disease in nine patients, severe pulmonary/cardiac disease in five patients, and postsurgical recurrences or metastatic disease in seven patients." | 1.27 | Inoperable esophageal carcinoma: results of aggressive synchronous radiotherapy and chemotherapy. A pilot study. ( Flam, M; John, M; Mowry, PA; Wittlinger, P, 1987) |
| "Mitomycin C (10 mg/m2) was administered as a bolus injection on day 2." | 1.27 | Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy. ( Coia, LR; Engstrom, PF; Paul, A, 1987) |
| "Mitomycin C (MMC) was used as a mutagen." | 1.27 | Elevated sister chromatid exchange frequencies in the lymphocytes of esophageal cancer patients. ( Adhvaryu, SG; Patel, JV; Rawal, UM, 1988) |
| " Compared to a group treated in 1970 bis 1982 with the same dosage of irradiation without the combination of chemotherapy the median survival could be raized from nine to 24 months, the two year survival rate improved from 18% to 42%." | 1.27 | [Simultaneous radio- and chemotherapy of squamous cell carcinoma of the esophagus]. ( Rohloff, R; Tosch, U; Wendt, TG; Willich, N, 1988) |
| "Out of 42 gastric cancer cases treated with only anticancer drugs, 37 cases exhibited hardly cytologic changes in the smears of biopsied materials." | 1.26 | [Cytological studies of esophageal carcinoma and gastric carcinoma receiving radiation and chemotherapy]. ( Asakawa, H; Nakano, N; Takeda, T, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (28.24) | 18.7374 |
| 1990's | 28 (32.94) | 18.2507 |
| 2000's | 22 (25.88) | 29.6817 |
| 2010's | 10 (11.76) | 24.3611 |
| 2020's | 1 (1.18) | 2.80 |
| Authors | Studies |
|---|---|
| Law, R | 1 |
| Ravi, K | 1 |
| Alexander, JA | 1 |
| Werner, D | 1 |
| Atmaca, A | 1 |
| Pauligk, C | 1 |
| Pustowka, A | 1 |
| Jäger, E | 1 |
| Al-Batran, SE | 1 |
| Ahlgren, J | 1 |
| Patel, N | 1 |
| Simmens, S | 1 |
| Akin, E | 1 |
| Bishop, C | 1 |
| Kirkel, D | 1 |
| Siegel, P | 1 |
| Schuck, S | 1 |
| Guebre-Xabiher, H | 1 |
| Siegel, R | 1 |
| Bartel, MJ | 1 |
| Seeger, K | 1 |
| Jeffers, K | 1 |
| Clayton, D | 1 |
| Wallace, MB | 1 |
| Raimondo, M | 1 |
| Woodward, TA | 1 |
| McDowell, LJ | 1 |
| Huang, SH | 1 |
| Xu, W | 1 |
| Che, J | 1 |
| Wong, RKS | 1 |
| Brierley, J | 2 |
| Kim, J | 1 |
| Cummings, B | 2 |
| Waldron, J | 1 |
| Bayley, A | 1 |
| Hansen, A | 1 |
| Witterick, I | 1 |
| Ringash, J | 2 |
| Lustberg, MB | 1 |
| Bekaii-Saab, T | 1 |
| Young, D | 1 |
| Otterson, G | 1 |
| Burak, W | 1 |
| Abbas, A | 1 |
| McCracken-Bussa, B | 1 |
| Lustberg, ME | 1 |
| Villalona-Calero, MA | 1 |
| Wolf, M | 1 |
| Zehentmayr, F | 2 |
| Niyazi, M | 1 |
| Ganswindt, U | 1 |
| Haimerl, W | 1 |
| Schmidt, M | 2 |
| Hölzel, D | 2 |
| Belka, C | 2 |
| Ma, G | 1 |
| Kawamura, K | 1 |
| Li, Q | 1 |
| Okamoto, S | 1 |
| Suzuki, N | 1 |
| Kobayashi, H | 1 |
| Liang, M | 1 |
| Tada, Y | 1 |
| Tatsumi, K | 1 |
| Hiroshima, K | 1 |
| Shimada, H | 1 |
| Tagawa, M | 1 |
| Wolf, MC | 1 |
| Machida, H | 1 |
| Tominaga, K | 1 |
| Minamino, H | 1 |
| Sugimori, S | 1 |
| Okazaki, H | 1 |
| Yamagami, H | 1 |
| Tanigawa, T | 1 |
| Watanabe, K | 1 |
| Watanabe, T | 2 |
| Fujiwara, Y | 1 |
| Arakawa, T | 1 |
| Slater, S | 1 |
| Shamash, J | 1 |
| Wilson, P | 1 |
| Gallagher, CJ | 1 |
| Slevin, ML | 1 |
| Tebbutt, NC | 2 |
| Norman, A | 2 |
| Cunningham, D | 2 |
| Iveson, T | 1 |
| Seymour, M | 1 |
| Hickish, T | 1 |
| Harper, P | 1 |
| Maisey, N | 1 |
| Mochlinski, K | 1 |
| Prior, Y | 1 |
| Hill, M | 2 |
| Zhang, ZQ | 1 |
| Du, WJ | 1 |
| Liu, LZ | 1 |
| Hofheinz, RD | 1 |
| Weisser, A | 1 |
| Willer, A | 1 |
| Hehlmann, R | 1 |
| Hochhaus, A | 1 |
| Kelleher, M | 1 |
| Andreyev, J | 1 |
| Allen, M | 1 |
| Nakamori, M | 1 |
| Iwahashi, M | 1 |
| Nakamura, M | 1 |
| Yamaue, H | 1 |
| Annino, DJ | 1 |
| Goguen, LA | 1 |
| MYHRE, K | 1 |
| FJAERLI, J | 1 |
| Darnton, SJ | 8 |
| Archer, VR | 2 |
| Stocken, DD | 2 |
| Mulholland, PJ | 2 |
| Casson, AG | 1 |
| Ferry, DR | 3 |
| Brega-Massone, PP | 1 |
| Conti, B | 1 |
| Lequaglie, C | 1 |
| Ferro, F | 1 |
| Cataldo, I | 1 |
| Zhuang, ZH | 1 |
| Wang, LD | 1 |
| Tsao, SW | 1 |
| Cheung, LM | 1 |
| Feng, HC | 1 |
| Yang, T | 1 |
| Qin, YR | 1 |
| Wang, CD | 1 |
| Chen, ZZ | 1 |
| Liu, B | 1 |
| Nabeya, Y | 1 |
| Ochiai, T | 2 |
| Ortner, MA | 1 |
| Taha, AA | 1 |
| Schreiber, S | 1 |
| Wirth, J | 1 |
| Weber-Eibl, J | 1 |
| Ernst, H | 1 |
| Lochs, H | 1 |
| Anderson, SE | 1 |
| Minsky, BD | 1 |
| Bains, M | 1 |
| Hummer, A | 1 |
| Kelsen, D | 2 |
| Ilson, DH | 1 |
| Han, JQ | 1 |
| Liu, Q | 1 |
| Liang, RX | 1 |
| Qu, FS | 1 |
| Yan, TX | 1 |
| Sun, YH | 1 |
| Li, XQ | 1 |
| Park, BB | 1 |
| Im, YH | 1 |
| Hwang, IG | 1 |
| Lee, SC | 1 |
| Ahn, JS | 1 |
| Ahn, MJ | 1 |
| Lim, HY | 1 |
| Kang, WK | 1 |
| Park, K | 1 |
| Yang, QS | 1 |
| Gu, JL | 1 |
| Du, LQ | 1 |
| Jia, LL | 1 |
| Qin, LL | 1 |
| Wang, Y | 2 |
| Fan, FY | 1 |
| Okuyama, K | 1 |
| Isono, K | 1 |
| Satoh, H | 2 |
| Onoda, S | 1 |
| Hayashi, R | 1 |
| Tohnosu, N | 1 |
| Yamamoto, Y | 1 |
| Chin, F | 1 |
| Kimura, M | 1 |
| Ryu, M | 1 |
| Kohzu, T | 1 |
| Odaka, M | 1 |
| Franklin, R | 1 |
| Steiger, Z | 3 |
| Vaishampayan, G | 1 |
| Asfaw, I | 2 |
| Rosenberg, J | 1 |
| Loh, J | 1 |
| Hoschner, J | 1 |
| Miller, P | 1 |
| Leichman, L | 2 |
| Seydel, HG | 1 |
| Vaitkevicius, VK | 1 |
| Nishi, I | 1 |
| Yokoyama, T | 1 |
| Nakao, I | 1 |
| Harashima, S | 1 |
| Ohashi, Y | 1 |
| Kanko, T | 1 |
| Saito, T | 1 |
| Gisselbrecht, C | 1 |
| Belpomme, D | 1 |
| Mignot, L | 1 |
| Marty, M | 1 |
| Mathé, G | 1 |
| Boiron, M | 1 |
| Takeda, T | 1 |
| Nakano, N | 1 |
| Asakawa, H | 1 |
| Aizawa, K | 1 |
| Tanaka, N | 1 |
| Yabusaki, H | 1 |
| Suzuki, S | 1 |
| Muto, I | 1 |
| Nishimaki, T | 1 |
| Suzuki, T | 1 |
| Hatakeyama, K | 1 |
| Tanaka, O | 1 |
| Kuwano, H | 1 |
| Sadanaga, N | 1 |
| Watanabe, M | 1 |
| Ikebe, M | 1 |
| Mori, M | 1 |
| Sugimachi, K | 1 |
| Algan, O | 1 |
| Coia, LR | 4 |
| Keller, SM | 2 |
| Engstrom, PF | 3 |
| Weiner, LM | 1 |
| Schultheiss, TE | 1 |
| Hanks, GE | 2 |
| Sauter, ER | 1 |
| Antonakopoulos, GN | 2 |
| Newman, J | 2 |
| Duffy, JP | 3 |
| Matthews, HR | 7 |
| Khansur, T | 1 |
| Allred, C | 1 |
| Tavassoli, M | 1 |
| Allen, SM | 4 |
| Walker, SJ | 2 |
| Cullen, MH | 3 |
| Edwards, CW | 1 |
| Jenner, K | 1 |
| Steyn, RS | 1 |
| Tanaka, T | 1 |
| Yamana, H | 1 |
| Fujita, H | 1 |
| Ono, T | 1 |
| Tou, Y | 1 |
| Fujii, T | 1 |
| Uhi, T | 1 |
| Shirouzu, K | 1 |
| Chauveinc, L | 1 |
| Giralt, EG | 1 |
| Braybrooke, JP | 1 |
| O'Byrne, KJ | 1 |
| Saunders, MP | 1 |
| Propper, DJ | 1 |
| Salisbury, AJ | 1 |
| Boardman, P | 1 |
| Taylor, M | 1 |
| Ganesan, TS | 1 |
| Talbot, DC | 1 |
| Harris, AL | 1 |
| Powell, ME | 1 |
| Hoskin, PJ | 1 |
| Saunders, MI | 1 |
| Foy, CJ | 1 |
| Dische, S | 1 |
| Sur, M | 1 |
| Taylor, L | 1 |
| Cooper, K | 1 |
| Sur, RK | 1 |
| Smith, TJ | 1 |
| Ryan, LM | 1 |
| Douglass, HO | 1 |
| Haller, DG | 1 |
| Dayal, Y | 1 |
| Kirkwood, J | 1 |
| Tormey, DC | 1 |
| Schutt, AJ | 1 |
| Hinson, J | 1 |
| Sischy, B | 1 |
| Hayter, CR | 1 |
| Huff-Winters, C | 1 |
| Paszat, L | 1 |
| Youssef, YM | 1 |
| Shelley, WE | 1 |
| Schulze, K | 1 |
| Delcambre, C | 1 |
| Jacob, JH | 1 |
| Pottier, D | 1 |
| Gignoux, M | 1 |
| Ollivier, JM | 1 |
| Vie, B | 1 |
| Roussel, A | 1 |
| Segol, P | 1 |
| Wong, CS | 1 |
| Catton, P | 1 |
| Catton, C | 1 |
| McLean, M | 1 |
| Keane, T | 1 |
| Panzarella, T | 1 |
| Zhou, C | 1 |
| Jia, J | 1 |
| Huang, T | 1 |
| Wang, B | 1 |
| Liu, X | 1 |
| Fu, X | 1 |
| Seitz, JF | 1 |
| Duffaud, F | 1 |
| Dahan, L | 1 |
| Ries, P | 1 |
| Ville, E | 1 |
| Laugier, R | 1 |
| Kawasaki, S | 1 |
| Akiyama, S | 1 |
| Kurokawa, T | 1 |
| Kataoka, M | 1 |
| Dohmitsu, K | 1 |
| Kondoh, K | 1 |
| Yamauchi, M | 1 |
| Ito, K | 1 |
| Sugiyama, S | 1 |
| Kikuchi, H | 1 |
| Kanamaru, R | 1 |
| Sato, Y | 1 |
| Tohma, H | 1 |
| Shikama, T | 1 |
| Paul, AR | 1 |
| Stafford, PM | 1 |
| Araújo, CM | 1 |
| Souhami, L | 1 |
| Gil, RA | 1 |
| Carvalho, R | 1 |
| Garcia, JA | 1 |
| Froimtchuk, MJ | 1 |
| Pinto, LH | 1 |
| Canary, PC | 1 |
| Steel, A | 1 |
| Aoki, T | 2 |
| Kimura, K | 1 |
| Koyanagi, Y | 1 |
| Sato, S | 1 |
| Tsuchida, A | 1 |
| Yoshimatsu, A | 1 |
| Ozawa, T | 1 |
| Yasuda, D | 1 |
| Kasuya, K | 1 |
| Nio, Y | 1 |
| Imai, S | 1 |
| Shiraishi, T | 1 |
| Tsubono, M | 1 |
| Morimoto, H | 1 |
| Tseng, CC | 1 |
| Tobe, T | 1 |
| Jinushi, K | 1 |
| Hirabayashi, N | 2 |
| Kirihara, Y | 1 |
| Takagami, S | 1 |
| Ryuji, K | 1 |
| Yorishima, T | 1 |
| Nishiyama, M | 2 |
| Noso, Y | 2 |
| Toge, T | 2 |
| Wu, YY | 1 |
| Yoshihara, T | 1 |
| Niimoto, M | 2 |
| Hirai, T | 1 |
| Miyoshi, Y | 1 |
| Ohtagaki, S | 1 |
| Hattori, T | 2 |
| Herskovic, A | 1 |
| Leichman, CG | 1 |
| Lattin, PB | 1 |
| Tapazoglou, E | 1 |
| Rosenberg, JC | 1 |
| Arbulu, A | 1 |
| Kinzie, J | 1 |
| Terashima, M | 1 |
| Ikeda, K | 1 |
| Satoh, M | 1 |
| Ishida, K | 1 |
| Yoshida, H | 1 |
| Mori, S | 1 |
| Inada, K | 1 |
| Yoshida, M | 1 |
| John, M | 2 |
| Flam, M | 2 |
| Wittlinger, P | 2 |
| Mowry, PA | 2 |
| Paul, A | 1 |
| Takegawa, Y | 1 |
| Sui, O | 1 |
| Hirose, C | 1 |
| Niki, T | 1 |
| Matsusaka, S | 1 |
| Chan, A | 1 |
| Wong, A | 1 |
| Arthur, K | 1 |
| Stewart, FM | 1 |
| Harkins, BJ | 1 |
| Hahn, SS | 1 |
| Daniel, TM | 1 |
| Petursson, SR | 1 |
| Podolsky, W | 1 |
| Padmanabhan, A | 1 |
| Wu, YQ | 1 |
| Yamaguchi, M | 1 |
| Adhvaryu, SG | 1 |
| Rawal, UM | 1 |
| Patel, JV | 1 |
| Tosch, U | 1 |
| Wendt, TG | 1 |
| Rohloff, R | 1 |
| Willich, N | 1 |
| Parker, EF | 1 |
| Marks, RD | 1 |
| Kratz, JM | 1 |
| Chaikhouni, A | 1 |
| Warren, ET | 1 |
| Bartles, DM | 1 |
| Keane, TJ | 1 |
| Harwood, AR | 1 |
| Elhakim, T | 1 |
| Rider, WD | 1 |
| Cummings, BJ | 1 |
| Ginsberg, RJ | 1 |
| Cooper, JC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase I Study of Daily RAD001 Administered Orally in Combination With Mitomycin C, Administered Every Three Weeks to Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction[NCT01042782] | Phase 1 | 16 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| Phase II Randomized Trial of Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer[NCT00201747] | Phase 2 | 80 participants (Actual) | Interventional | 2001-09-30 | Completed | ||
| Effectiveness Evaluation of Mixed Gel of Hydrocortisone and Aluminium Phosphate Preventing Endoscopic Submucosal Dissection Postoperative Stenosis for Patients With Early Esophageal Cancer Invading More Than 2/3 Esophageal Perimeter[NCT03165344] | 66 participants (Actual) | Interventional | 2017-02-10 | Completed | |||
| A Prospective, Single-arm Study of Simultaneous Modulated Accelerated Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Carcinoma.[NCT02606916] | Phase 2 | 42 participants (Actual) | Interventional | 2015-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for mitomycin and Cancer of Esophagus
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Topical Mitomycin C application in the treatment of refractory benign esophageal strictures in adults and comprehensive literature review.
Topics: Aged; Alkylating Agents; Anastomosis, Surgical; Balloon Occlusion; Caustics; Constriction, Pathologi | 2016 |
[Chemotherapy for esophageal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Esophageal Neoplasms; Fluorour | 2003 |
Chemotherapy of esophageal cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorub | 1984 |
Combined infusional chemotherapy and radiation for esophageal carcinoma: a review.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Clinica | 1995 |
22 trials available for mitomycin and Cancer of Esophagus
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose | 2013 |
Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carcin | 2010 |
Locoregional mitomycin C injection for esophageal stricture after endoscopic submucosal dissection.
Topics: Aged; Carcinoma; Catheterization; Deglutition Disorders; Dissection; Esophageal Neoplasms; Esophagea | 2012 |
A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 2002 |
Mitomycin C, carboplatin and protracted venous infusion 5-fluorouracil in advanced oesophago-gastric and pancreatic cancer: results of two phase II studies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Esophageal Neoplasms; Fema | 2003 |
Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: pathologic complete response induced by chemotherapy leads to long-term survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Co | 2003 |
Endoscopic injection of mitomycin adsorbed on carbon particles for advanced esophageal cancer: a pilot study.
Topics: Adsorption; Adult; Aged; Antibiotics, Antineoplastic; Carbon; Carcinoma, Squamous Cell; Drug Carrier | 2004 |
Combined modality chemoradiation in elderly oesophageal cancer patients.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 2007 |
Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Di | 2008 |
[Clinical study of hyperthermia combined with chemotherapy in the treatment of carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, A | 1993 |
Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Comb | 1995 |
Preoperative high-dose radiation and chemotherapy in adenocarcinoma of the esophagus and esophagogastric junction.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Eso | 1994 |
A phase II study of mitomycin, ifosfamide and cisplatin in operable and inoperable squamous cell carcinoma of the oesophagus.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophagea | 1994 |
Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagus.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 1996 |
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemot | 1997 |
Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Comb | 1998 |
A prospective trial of short-course radiotherapy plus chemotherapy for palliation of dysphagia from advanced esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2000 |
Combined results from three phase II trials of neoadjuvant chemotherapy in operable adenocarcinoma of the oesophagus.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisp | 2001 |
[Clinical observation on effect of yiqi huoxue decoction in comprehensive treatment on advanced stage of esophageal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Co | 1999 |
[Chemotherapy for advanced and recurrent cancer patients--the effect of combination chemotherapy using cisplatin, peplomycin, mitomycin C, adriamycin, and 5-fluorouracil].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Colorectal Neopla | 1990 |
A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Co | 1991 |
59 other studies available for mitomycin and Cancer of Esophagus
| Article | Year |
|---|---|
A rash decision?
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Diagnosis, Differential; Esophageal Neoplasms; Exanthem | 2013 |
O-MAX chemotherapy: high activity in metastatic esophagogastric adenocarcinoma and possible relation to subclinical hemolysis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycyti | 2014 |
Effect of Intensity Modulated Radiation Therapy With Concurrent Chemotherapy on Survival for Patients With Cervical Esophageal Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined | 2017 |
Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2010 |
Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma.
Topics: Adenoviridae; Adenovirus E1B Proteins; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cel | 2010 |
Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2012 |
Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers - a new active regimen.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma | 2002 |
[Observation on effects of qige tongye decoction combined with chemotherapy in treating esophageal carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin | 2002 |
Treatment of a patient with advanced esophageal cancer with a combination of mitomycin C and capecitabine: activation of the thymidine phosphorylase as active principle?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Deoxy | 2003 |
Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuva | 2003 |
Mitomycin C for the treatment of pharyngoesophageal stricture after total laryngopharyngectomy and microvascular free tissue reconstruction.
Topics: Adenocarcinoma; Administration, Topical; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; | 2003 |
TREATMENT OF MALIGNANT TUMOURS WITH 5-FLUOROURACIL IN 80 PATIENTS.
Topics: Biomedical Research; Breast Neoplasms; Colonic Neoplasms; Drug Therapy; Esophageal Neoplasms; Female | 1964 |
[The role of surgical therapy for esophageal microcytoma. Experience of there clinical cases and results analysis].
Topics: Aged; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, | 2003 |
[Cyclooxygenase-2 expression in esophageal cancer cells and induction by mitomycin C].
Topics: Antibiotics, Antineoplastic; Apoptosis; Cyclooxygenase 2; Esophageal Neoplasms; Gene Expression Regu | 2003 |
[Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Comb | 2007 |
ShRNA-mediated Ku80 gene silencing inhibits cell proliferation and sensitizes to gamma-radiation and mitomycin C-induced apoptosis in esophageal squamous cell carcinoma lines.
Topics: Antigens, Nuclear; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; DNA-Bi | 2008 |
[Effect of continuous intra-arterial infusion therapy with BLM-MMC-lentinan (B-M-L) in treating patients with hepatic metastases of esophageal cancer].
Topics: Aged; Bleomycin; Drug Therapy, Combination; Esophageal Neoplasms; Female; Humans; Infusions, Intra-A | 1982 |
Combined modality therapy for esophageal squamous cell carcinoma.
Topics: Abdomen; Adult; Aged; Carcinoma, Squamous Cell; Drug Therapy, Combination; Esophageal Neoplasms; Eso | 1983 |
Combined preoperative chemotherapy and radiation therapy for cancer of the esophagus: the Wayne State University, Southwest Oncology group and Radiation Therapy Oncology Group experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modali | 1984 |
[Phase II study of KW 2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with various cancers].
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Anorexia; Antibiotics, Antineoplastic; Aspartate Amin | 1984 |
Chemotherapy of carcinomas of the digestive tract.
Topics: Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Esop | 1982 |
[Cytological studies of esophageal carcinoma and gastric carcinoma receiving radiation and chemotherapy].
Topics: Antineoplastic Agents; Cytodiagnosis; Esophageal Neoplasms; Humans; Mitomycin; Mitomycins; Radiother | 1982 |
Chemotherapy of human small-cell gastrointestinal carcinoma xenografts in nude mice.
Topics: Aged; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating | 1995 |
Effects of chemotherapy on ultrastructure of oesophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 1994 |
5-Fluorouracil, adriamycin, and mitomycin C in adenocarcinoma of the esophagus or gastroesophageal junction tumors.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Esophageal | 1994 |
Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1993 |
Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Tr | 1995 |
[An experimental study on antitumor effect of MMC-fibrin glue mixture].
Topics: Animals; Esophageal Neoplasms; Fibrin Tissue Adhesive; Mice; Mice, Nude; Mitomycin; Stomach Neoplasm | 1996 |
Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cisp | 1997 |
Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Membe | 1997 |
Localized squamous-cell cancer of the esophagus: retrospective analysis of three treatment schedules.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cause of Death; Cisplatin; | 2001 |
Squamous cell carcinoma of the oesophagus treated with radiation and 5-fluorouracil, with and without mitomycin C.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Clinical Trials as T | 2001 |
Endoscopic Nd:YAG laser therapy combined with local chemotherapy of superficial carcinomas of the oesophagus and gastric cardia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cardia; Combined Modality Th | 2001 |
[Adenocarcinomas of the distal esophagus and gastric cardia: what chemotherapy or chemoradiotherapy for recurrent or metastatic disease?].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cardia; Cisplatin; Combined Modality | 2001 |
Polyoxyethylene-modified superoxide dismutase reduces side effects of adriamycin and mitomycin C.
Topics: Animals; Carcinoma, Squamous Cell; Doxorubicin; Drug Screening Assays, Antitumor; Electron Transport | 1992 |
Effects of chemotherapy on ultrastructure of oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Nucleolus; Cisplat | 1992 |
[Chemotherapy-associated hemolytic uremic syndrome--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; | 1992 |
Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; | 1991 |
A phase II study of 5-fluorouracil, adriamycin and mitomycin-C in adenocarcinoma of the oesophagus.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dox | 1991 |
[Study of intermittent intra-arterial infusion chemotherapy in liver metastases from squamous cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubic | 1991 |
Chemosensitivity correlation between the primary tumors and simultaneous metastatic lymph nodes of patients evaluated by DNA synthesis inhibition assay.
Topics: Breast Neoplasms; Carbazilquinone; Cisplatin; Colorectal Neoplasms; DNA, Neoplasm; Doxorubicin; Drug | 1990 |
[Clinical studies of in vitro chemosensitivity test evaluated by ATP assay of gastrointestinal cancer].
Topics: Adenosine Triphosphate; Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Scree | 1990 |
[Human LAK cell induction and its biological characteristics].
Topics: Antibodies, Monoclonal; Antigens, CD; Cytotoxicity Tests, Immunologic; Esophageal Neoplasms; Female; | 1990 |
[Combination chemotherapy with cis-diamminedichloroplatinum (CDDP) and other anticancer agents for patients with advanced esophageal cancer].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cispl | 1985 |
Nonoperative therapy for squamous-cell cancer of the esophagus.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin | 1987 |
[Analysis of the chemosensitivity test by subrenal capsule assay].
Topics: Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Colonic Neoplasms; Colony-Forming Units Assay; | 1987 |
Inoperable esophageal carcinoma: results of aggressive synchronous radiotherapy and chemotherapy. A pilot study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; C | 1987 |
Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 1987 |
[Combination of radiotherapy with chemotherapy using cisplatin in advanced esophageal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Eso | 1988 |
Concomitant 5-fluorouracil infusion, mitomycin C and radical radiation therapy in esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; | 1989 |
Cisplatin, 5-fluorouracil, mitomycin C, and concurrent radiation therapy with and without esophogectomy for esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 1989 |
Adenoid cystic carcinoma of the esophagus. Complete response to combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Adenoid Cystic; Cisplati | 1986 |
Clinical evidence of feasibility and efficacy of simultaneous irradiation and chemotherapy in advanced squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Brachytherapy; Carcinom | 1986 |
[Genetic etiology of esophageal cancer--III. The spontaneous and mitomycin-C (MMC) induced sister chromatid exchanges (SCE) and chromosome aberrations in cultured lymphocytes from members of "high risk" and "low risk" esophageal cancer families in Linxian
Topics: Adolescent; Adult; Aged; Child; China; Chromosome Aberrations; Esophageal Neoplasms; Female; Humans; | 1986 |
Prediction of individual tumor chemosensitivity in subrenal capsule assay.
Topics: Animals; Antineoplastic Agents; Cisplatin; Colony-Forming Units Assay; Cyclophosphamide; Doxorubicin | 1986 |
Elevated sister chromatid exchange frequencies in the lymphocytes of esophageal cancer patients.
Topics: Cell Cycle; Esophageal Neoplasms; Humans; Lymphocytes; Mitomycin; Mitomycins; Sister Chromatid Excha | 1988 |
[Simultaneous radio- and chemotherapy of squamous cell carcinoma of the esophagus].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 1988 |
Chemoradiation therapy and resection for carcinoma of the esophagus: short-term results.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 1985 |
Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 1985 |